Adjuncts to Mechanical Ventilation in ARDS

Seminars in Thoracic and Cardiovascular Surgery

Volumn 18, Issue 1, 2006, Pages 20-27

  Lynch, James E ^a   Cheek, J Mark ^a   Chan, Edward Y ^a   Zwischenberger, Joseph B ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

adult respiratory distress syndrome (ARDS); arterial venous carbon dioxide removal (AVCO2R); extracorporeal membrane oxygenation (ECMO); liquid ventilation; nitric oxide; prone positioning

Indexed keywords

CARBON DIOXIDE; DIPALMITOYLPHOSPHATIDYLCHOLINE; LUNG SURFACTANT; NITRIC OXIDE; SURFACTANT PROTEIN C;

ADULT RESPIRATORY DISTRESS SYNDROME; ARTERIAL CARBON DIOXIDE TENSION; ARTERIAL GAS; ARTICLE; ARTIFICIAL VENTILATION; BODY POSTURE; CLINICAL TRIAL; EVIDENCE BASED MEDICINE; EXTRACORPOREAL OXYGENATION; HUMAN; LIQUID VENTILATION; LUNG GAS EXCHANGE; LUNG INJURY; SURVIVAL;

CARBON DIOXIDE; EXTRACORPOREAL CIRCULATION; EXTRACORPOREAL MEMBRANE OXYGENATION; HUMANS; LIQUID VENTILATION; NITRIC OXIDE; PRONE POSITION; PULMONARY GAS EXCHANGE; PULMONARY SURFACTANTS; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, ADULT; TIDAL VOLUME;

EID: 33744788633     PISSN: 10430679     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semtcvs.2006.01.005     Document Type: Article

References (72)

1. Ashbaugh D.G., Bigelow D.B., Petty T.L., et al. Acute respiratory distress in adults. Lancet 2 (1967) 319-323
2. Pinhu L., Whitehead T., Evans T., et al. Ventilator-associated lung injury. Lancet 361 (2003) 332-340
3. Chiumello D., Pristine G., and Slutsky A.S. Mechanical ventilation affects local and systemic cytokines in an animal model of acute respiratory distress syndrome. Am J Respir Crit Care Med 160 (1999) 109-116
4. Tremblay L., Valenza F., Ribeiro S.P., et al. Injurious ventilatory strategies increase cytokines and c-fos m-RNA expression in an isolated rat lung model. J Clin Invest 99 (1997) 944-952
5. The Acute Respiratory Distress Syndrome Network. Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 342 (2000) 1301-1308
6. Piehl M.A., and Brown R.S. Use of extreme position changes in acute respiratory failure. Crit Care Med 4 (1976) 13-14
7. Douglas W.W., Rehder K., Beynen F.M., et al. Improved oxygenation in patients with acute respiratory failure. the prone position. Am Rev Respir Dis 115 (1977) 559-566
8. Marini J.J., and Rubenfeld G. Pro/con clinical debate. the use of prone positioning in the management of patients with acute respiratory distress syndrome. Crit Care 6 (2002) 15-17
9. Cakar N., der Kloot T.V., Youngblood M., et al. Oxygenation response to a recruitment maneuver during supine and prone positions in an oleic acid-induced lung injury model. Am J Respir Crit Care Med 161 (2000) 1949-1956
10. Broccard A., Shapiro R.S., Schmitz L.L., et al. Prone positioning attenuates and redistributes ventilator-induced lung injury in dogs. Crit Care Med 28 (2000) 295-303
11. Broccard A.F., Shapiro R.S., Schmitz L.L., et al. Influence of prone position on the extent and distribution of lung injury in a high tidal volume oleic acid model of acute respiratory distress syndrome. Crit Care Med 25 (1997) 16-27
12. Gattinoni L., Tognoni G., Pesenti A., et al. Effect of prone positioning on the survival of patients with acute respiratory failure. N Engl J Med 345 (2001) 568-573
13. Slutsky A.S. The acute respiratory distress syndrome, mechanical ventilation, and the prone position. N Engl J Med 345 (2001) 610-612
14. Varkul M.D., Stewart T.E., Lapinsky S.E., et al. Successful use of combined high-frequency oscillatory ventilation, inhaled nitric oxide, and prone positioning in the acute respiratory distress syndrome. Anesthesiology 95 (2001) 797-799
15. Papazian L., Bregeon F., Gaillat F., et al. Respective and combined effects of prone position and inhaled nitric oxide in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 157 (1998) 580-585
16. Ignarro L.J., Buga G.M., Wood K.S., et al. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 84 (1987) 9265-9269
17. Koh Y., and Hurford W.E. Inhaled nitric oxide in acute respiratory distress syndrome. from bench to bedside. Int Anesthesiol Clin 41 (2003) 91-102
18. Giaid A., and Saleh D. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N Engl J Med 333 (1995) 214-221
19. Gerlach H., Rossaint R., Pappert D., et al. Time-course and dose-response of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndrome. Eur J Clin Invest 23 (1993) 499-502
20. Roberts J.D., Polaner D.M., Lang P., et al. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 340 (1992) 818-819
21. Clark R.H., Kueser T.J., Walker M.W., et al., Clinical Inhaled Nitric Oxide Research Group. Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. N Engl J Med 342 (2000) 469-474
22. The Neonatal Inhaled Nitric Oxide Study Group. Neonatal Inhaled Nitric Oxide Study Group. Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. N Engl J Med 336 (1997) 597-604
23. Puybasset L., Rouby J.J., Mourgeon E., et al. Factors influencing cardiopulmonary effects of inhaled nitric oxide in acute respiratory failure. Am J Respir Crit Care Med 152 (1995) 318-328
24. Sokol J., Jacobs S.E., and Bohn D. Inhaled nitric oxide for acute hypoxemic respiratory failure in children and adults. Cochrane Database Syst Rev (2003) CD002787
25. Taylor R.W., Zimmerman J.L., Dellinger R.P., et al. Low-dose inhaled nitric oxide in patients with acute lung injury. a randomized controlled trial. JAMA 291 (2004) 1603-1609
26. Clancy R.M., Leszczynska-Piziak J., and Abramson S.B. Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase. J Clin Invest 90 (1992) 1116-1121
27. Riddell D.R., and Owen J.S. Nitric oxide and platelet aggregation. Vitam Horm 57 (1999) 25-48
28. Hickey M.J., and Kubes P. Role of nitric oxide in regulation of leucocyte-endothelial cell interactions. Exp Physiol 82 (1997) 339-348
29. Rayhrer C.S., Edmisten T.D., Cephas G.A., et al. Nitric oxide potentiates acute lung injury in an isolated rabbit lung model. Ann Thorac Surg 65 (1998) 935-938
30. Angus D.C., Clermont G., Watson R.S., et al. Cost-effectiveness of inhaled nitric oxide in the treatment of neonatal respiratory failure in the United States. Pediatrics 112 (2003) 1351-1360
31. Griffiths M.J., and Evans T.W. Inhaled nitric oxide therapy in adults. N Engl J Med 353 (2005) 2683-2695
32. Lewis J.F., and Jobe A.H. Surfactant and the adult respiratory distress syndrome. Am Rev Respir Dis 147 (1993) 218-233
33. Schreiber M.D., Gin-Mestan K., Marks J.D., et al. Inhaled nitric oxide in premature infants with the respiratory distress syndrome. N Engl J Med 349 (2003) 2099-2107
34. Anzueto A., Baughman R.P., Guntupalli K.K., et al., Exosurf Acute Respiratory Distress Syndrome Sepsis Study Group. Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. N Engl J Med 334 (1996) 1417-1421
35. Gregory T.J., Steinberg K.P., Spragg R., et al. Bovine surfactant therapy for patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 155 (1997) 1309-1315
36. Spragg R.G., Lewis J.F., Walmrath H.D., et al. Effect of recombinant surfactant protein C-based surfactant on the acute respiratory distress syndrome. N Engl J Med 351 (2004) 884-892
37. Hill J.D., O'Brien T.G., Murray J.J., et al. Prolonged extracorporeal oxygenation for acute post-traumatic respiratory failure (shock-lung syndrome). Use of the Bramson membrane lung. N Engl J Med 286 (1972) 629-634
38. Bartlett R.H. Extracorporeal life support for cardiopulmonary failure. Curr Probl Surg 27 (1990) 621-705
39. Bartlett R.H., Gazzaniga A.B., Jefferies M.R., et al. Extracorporeal membrane oxygenation (ECMO) cardiopulmonary support in infancy. Trans Am Soc Artif Intern Organs 22 (1976) 80-93
40. ECMO Registry of the Extracorporeal Life Support Organization (ELSO) Ann Arbor, Michigan (December, 2005)
41. Bartlett R.H., Roloff D.W., Cornell R.G., et al. Extracorporeal circulation in neonatal respiratory failure. a prospective randomized study. Pediatrics 76 (1985) 479-487
42. O'Rourke P.P., Crone R.K., Vacanti J.P., et al. Extracorporeal membrane oxygenation and conventional medical therapy in neonates with persistent pulmonary hypertension of the newborn. a prospective randomized study. Pediatrics 84 (1989) 957-963
43. UK Collaborative ECMO Trail Group. UK Collaborative ECMO Trial Group. UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation. Lancet 348 (1996) 75-82
44. Zapol W.M., Snider M.T., Hill J.D., et al. Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study. JAMA 242 (1979) 2193-2196
45. Hemmila M.R., Rowe S.A., Boules T.N., et al. Extracorporeal life support for severe acute respiratory distress syndrome in adults. Ann Surg 240 (2004) 595-605 discussion 605-597
46. Kolla S., Awad S.S., Rich P.B., et al. Extracorporeal life support for 100 adult patients with severe respiratory failure. Ann Surg 226 (1997) 544-564 discussion 565-546
47. Lewandowski K., Rossaint R., Pappert D., et al. High survival rate in 122 ARDS patients managed according to a clinical algorithm including extracorporeal membrane oxygenation. Intensive Care Med 23 (1997) 819-835
48. Peek G.J., Moore H.M., Moore N., et al. Extracorporeal membrane oxygenation for adult respiratory failure. Chest 112 (1997) 759-764
49. 2R). an experimental study. Anesth Analg 57 (1978) 470-477
50. Gattinoni L., Kolobow T., Tomlinson T., et al. Control of intermittent positive pressure breathing (IPPB) by extracorporeal removal of carbon dioxide. Br J Anaesth 50 (1978) 753-758
51. Kolobow T., Gattinoni L., Tomlinson T., et al. An alternative to breathing. J Thorac Cardiovasc Surg 75 (1978) 261-266
52. Brunet F., Belghith M., Mira J.P., et al. Extracorporeal carbon dioxide removal and low-frequency positive-pressure ventilation. Improvement in arterial oxygenation with reduction of risk of pulmonary barotrauma in patients with adult respiratory distress syndrome. Chest 104 (1993) 889-898
53. Morris A.H., Wallace C.J., Menlove R.L., et al. Randomized clinical trial of pressure-controlled inverse ratio ventilation and extracorporeal CO2 removal for adult respiratory distress syndrome. Am J Respir Crit Care Med 149 (1994) 295-305
54. Brunston Jr. R.L., Tao W., Bidani A., et al. Organ blood flow during arteriovenous carbon dioxide removal. ASAIO J 43 (1997) M821-M824
55. 2 removal. simplifying extracorporeal support for respiratory failure. Ann Thorac Surg 64 (1997) 1599-1604 discussion 1604-1595
56. Conrad S.A., Zwischenberger J.B., Grier L.R., et al. Total extracorporeal arteriovenous carbon dioxide removal in acute respiratory failure. a phase I clinical study. Intensive Care Med 27 (2001) 1340-1351
57. 2 removal for severe respiratory failure. Ann Thorac Surg 68 (1999) 181-187
58. Liebold A., Philipp A., Kaiser M., et al. Pumpless extracorporeal lung assist using an arterio-venous shunt. Applications and limitations. Minerva Anesthesiol 68 (2002) 387-391
59. Kylstra J.A., and Schoenfisch W.H. Alveolar surface tension in fluorocarbon-filled lungs. J Appl Physiol 33 (1972) 32-35
60. Clark Jr. L.C., and Gollan F. Survival of mammals breathing organic liquids equilibrated with oxygen at atmospheric pressure. Science 152 (1966) 1755-1756
61. Moskowitz G.D. A mechanical respirator for control of liquid breathing. Fed Proc 29 (1970) 1751-1752
62. Moskowitz G.D., Shaffer T.H., and Dubin S.E. Liquid breathing trials and animal studies with a demand-regulated liquid breathing system. Med Instrum 9 (1975) 28-33
63. Shaffer T.H., and Moskowitz G.D. Demand-controlled liquid ventilation of the lungs. J Appl Physiol 36 (1974) 208-213
64. Richman P.S., Wolfson M.R., and Shaffer T.H. Lung lavage with oxygenated perfluorochemical liquid in acute lung injury. Crit Care Med 21 (1993) 768-774
65. Hirschl R.B., Parent A., Tooley R., et al. Liquid ventilation improves pulmonary function, gas exchange, and lung injury in a model of respiratory failure. Ann Surg 221 (1995) 79-88
66. Hirschl R.B., Tooley R., Parent A.C., et al. Improvement of gas exchange, pulmonary function, and lung injury with partial liquid ventilation. A study model in a setting of severe respiratory failure. Chest 108 (1995) 500-508
67. Greenspan J.S., Wolfson M.R., Rubenstein S.D., et al. Liquid ventilation of human preterm neonates. J Pediatr 117 (1990) 106-111
68. Tredici S., Komori E., Funakubo A., et al. A prototype of a liquid ventilator using a novel hollow-fiber oxygenator in a rabbit model. Crit Care Med 32 (2004) 2104-2109
69. Leach C.L., Greenspan J.S., Rubenstein S.D., et al., The LiquiVent Study Group. Partial liquid ventilation with perflubron in premature infants with severe respiratory distress syndrome. N Engl J Med 335 (1996) 761-767
70. Hirschl R.B. Liquid ventilation in the setting of respiratory failure. ASAIO J 44 (1998) 231-233
71. Hirschl R.B., Conrad S., Kaiser R., et al., Adult PLV Study Group. Partial liquid ventilation in adult patients with ARDS. a multicenter phase I-II trial. Ann Surg 228 (1998) 692-700
72. Hirschl R.B., Croce M., Gore D., et al. Prospective, randomized, controlled pilot study of partial liquid ventilation in adult acute respiratory distress syndrome. Am J Respir Crit Care Med 165 (2002) 781-787